Cargando…
An MCASE approach to the search of a cure for Parkinson's Disease.
BACKGROUND: Parkinson's disease is caused by a dopamine deficiency state in the fore brain area. Dopamine receptor agonists, MAO-B inhibitors, and N-Methyl-D-Aspartate (NMDA) receptor antagonists are known to have antiparkinson effect. Levodopa, a dopamine structural analog, is the best current...
Autores principales: | Klopman, Gilles, Sedykh, Aleksandr |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC107836/ https://www.ncbi.nlm.nih.gov/pubmed/11926966 http://dx.doi.org/10.1186/1471-2210-2-8 |
Ejemplares similares
-
Predicting toxicity through a computer automated structure evaluation program.
por: Klopman, G
Publicado: (1985) -
The search for a chemical cure for cancer.
por: MacGregor, A B
Publicado: (1966) -
Burning mouth syndrome in Parkinson’s disease: dopamine as cure or cause?
por: Coon, Elizabeth A., et al.
Publicado: (2012) -
Regenerative medicine: could Parkinson's be the first neurodegenerative disease to be cured?
por: Díaz, Mariacruz L
Publicado: (2019) -
Gene therapy in the putamen for curing AADC deficiency and Parkinson's disease
por: Hwu, Paul Wuh‐Liang, et al.
Publicado: (2021)